ArticleHepatology (Baltimore, Md.)2017
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
Article in Hepatology (Baltimore, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04014413 (Safety and Efficacy of Fecal Microbiota Transplantation), which is not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Safety and Efficacy of Fecal Microbiota Transplantation: A Pilot Study
Who cites it
17 citing papers in PubMed.
- Advances in understanding, diagnosing, and treating hepatic encephalopathy: from epidemiology to emerging therapies.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy.Medical science monitor : international medical journal of experimental and clinical research · 2025Review
- [Clinical treatment controversies and progress in liver cirrhosis: an evidence-based medicine perspective from managing portal hypertension to preventing complications].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025Article
- Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis.World journal of hepatology · 2025Article
- Article
- Microbiota-gut-liver-brain axis and hepatic encephalopathy.Microbiome research reports · 2024Review
- The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases.The American journal of pathology · 2023Review
- Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.Cell & bioscience · 2022Review
- Hepatic encephalopathy.Nature reviews. Disease primers · 2022Review
- Leveraging diet to engineer the gut microbiome.Nature reviews. Gastroenterology & hepatology · 2021Review
- Gut microbiome in liver pathophysiology and cholestatic liver disease.Liver research (Beijing, China) · 2021Article
- Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease.Frontiers in microbiology · 2020Article
- Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease.International journal of hepatology · 2020Article
- A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research.Nature medicine · 2019Article
- Microbial Profiles of Cirrhosis in the Human Small Intestine.Current gastroenterology reports · 2019Review
- Article
- The recognition and attitudes of postgraduate medical students toward fecal microbiota transplantation: a questionnaire study.Therapeutic advances in gastroenterology · 2019Article
Corrections and comments
- Commented on byReply.2017
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28714089What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.